Ooshima Y, Chatani F, Sugitani T, Tanakamaru Z, Fuji J
Drug Safety Research Laboratories, Takeda Chemical Industries, Ltd., Yamaguchi, Japan.
J Toxicol Sci. 1995 Aug;20(3):229-38. doi: 10.2131/jts.20.229.
To assess the optimal dosing period and parameters for measurement of effects on male fertility, Compound T was administered to male Jcl:Wistar rats at dosage levels of 0, 2, 10 and/or 50 mg/kg/day for 4 weeks (Experiment 1) or for 9 weeks (Experiment 2). Experiment 1: In the 50 mg/kg group, the ventral prostate weight was low when compared to the control value, and desquamation of round spermatids was observed in the testes. Experiment 2: When treated males were mated with untreated females after dosing for 9 weeks (the first mating), the fertility index was slightly lowered and preimplantation loss was significantly elevated in the 50 mg/kg group as compared to the control values. In this treatment group, serum testosterone level at 2.5 hours after dosing was significantly decreased after dosing for 12 weeks, and degeneration of spermatids/spermatocytes in the testis and epididymis was observed after dosing for 13 weeks. After a recovery period of for 6 weeks, remating resulted in copulatory and fertility indices and cesarean section data which were comparable in all groups. In conclusion, there were no differences in toxicity relevant to male fertility between 4 and 9 weeks of dosing, and it is considered that the observed changes resulted from decreased function of Sertoli cells due to depressed production/secretion of testosterone.
为评估影响雄性生育力的最佳给药周期及测量效应的参数,将化合物T以0、2、10和/或50 mg/kg/天的剂量水平给予雄性Jcl:Wistar大鼠,持续给药4周(实验1)或9周(实验2)。实验1:在50 mg/kg组中,腹侧前列腺重量与对照值相比降低,且在睾丸中观察到圆形精子细胞的脱落。实验2:给药9周后(首次交配),将处理过的雄性与未处理的雌性交配,50 mg/kg组的生育指数略有降低,着床前损失与对照值相比显著升高。在该治疗组中,给药12周后给药后2.5小时的血清睾酮水平显著降低,给药13周后观察到睾丸和附睾中的精子细胞/精母细胞退化。经过6周的恢复期后,再次交配产生的交配和生育指数以及剖腹产数据在所有组中具有可比性。总之,给药4周和9周之间在与雄性生育力相关的毒性方面没有差异,并且认为观察到的变化是由于睾酮产生/分泌受抑制导致支持细胞功能下降所致。